Adipose Tissue and Cancer

CHF 202.20
Auf Lager
SKU
1GBFRK3VJ37
Stock 1 Verfügbar
Geliefert zwischen Mi., 26.11.2025 und Do., 27.11.2025

Details

This book discusses data suggesting the role of adipose tissue in cancer, and examines mechanisms - such as tumor vascularization and immune system suppression - through which excess or restriction of adipose tissue could influence cancer progression.

Recent studies have shown that cells from adipose tissue are capable of trafficking to tumors, thus enabling paracrine action of adipokines from within the tumor microenvironment. Increased tumor vascularization, immune system suppression and direct effects on malignant cell survival and proliferation have been investigated as mechanisms regulated by adipokines. The goal of this book is to discuss data pointing to the role of adipose tissue in cancer and to dissect individual mechanisms through which adipose tissue excess or restriction could influence cancer progression.

Explores relationship between obesity and cancer Examines direct effect of adipose tissue on cancer Discusses role of endocrine signaling by adipose tissue-derived molecules in cancer promotion

Klappentext

The pathophysiology underlying the relationship between obesity and cancer is complex and incompletely understood. Progression of certain cancers has been shown to accelerate in obese patients irrespective of their lifestyle and diet. Because obesity is manifested by overgrowth of white adipose tissue, it has been proposed that adipose tissue has a direct effect on cancer progression.

Adipose tissue is composed of several types of cells secreting numerous soluble factors collectively termed adipokines. In addition, infiltration of the immune system cells in obesity leads to increased production of a number of inflammatory factors by adipose tissue, thus contributing to the establishment of the metabolic syndrome. Endocrine signaling by adipose tissue-derived molecules has been shown to promote cancer in animal models, matching clinical associations. Recent studies have shown that cells from adipose tissue are capable of trafficking to tumors, thus enabling paracrine action of adipokines from within the tumor microenvironment. Increased tumor vascularization, immune system suppression and direct effects on malignant cell survival and proliferation have been investigated as mechanisms regulated by adipokines.

This volume will discuss clinical and experimental data pointing to the role of adipose tissue in cancer and to dissect individual mechanisms through which adipose tissue excess or restriction could influence cancer progression.


Inhalt
Preface: Obesity, Adipose Tissue and Cancer Progression.- Metabolic Perturbations Associated with Adipose Tissue Dysfunction and the Obesity-Cancer Link.- Increased Adiposity and Colorectal Cancer.- Adiposity and Diabetes in Breast and Prostate Cancer.- Increased Adipocity and Endometrial Cancer Risk.- Adipokines: Soluble Factors from Adipose Tissue Implicated in Cancer.- Animal Models to Study the Interplay between Cancer and Obesity.- Unraveling the local influence of tumor-surrounding adipose tissue on tumor progression: cellular and molecular actors involved.- Trafficking of Cells from Adipose Tissue to Tumor Microenvironment.- The Impact of Obesity Intervention on Cancer: Clinical Perspectives.- Index.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor Mikhail G. Kolonin
    • Titel Adipose Tissue and Cancer
    • Veröffentlichung 17.07.2013
    • ISBN 1461476593
    • Format Fester Einband
    • EAN 9781461476597
    • Jahr 2013
    • Größe H241mm x B160mm x T15mm
    • Gewicht 471g
    • Auflage 2013
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 200
    • Herausgeber Springer New York
    • GTIN 09781461476597

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470